
Progyny PGNY
$ 17.39
1.28%
Quarterly report 2025-Q3
added 11-07-2025
Progyny Cash Conversion Cycle 2011-2026 | PGNY
Annual Cash Conversion Cycle Progyny
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121 | 125 | 36.6 | 27.4 | 23.2 | 36.4 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 125 | 23.2 | 61.5 |
Quarterly Cash Conversion Cycle Progyny
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.3 | 26.9 | 31.1 | - | 34.8 | - | - | - | 31.9 | 36.9 | 39.5 | - | 27.5 | 20.8 | 40.3 | 44.5 | 49.4 | 39.7 | 22.5 | 19 | 18.9 | 31.4 | 24.6 | 32.8 | 34 | 36.9 | 25.2 | 13.1 | 7.04 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 49.4 | 7.04 | 29.8 |
Cash Conversion Cycle of other stocks in the Health information services industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accolade
ACCD
|
-4.64 | - | 0.29 % | $ 206 M | ||
|
Cerner Corporation
CERN
|
-20 | - | - | $ 27.9 B | ||
|
Computer Programs and Systems
CPSI
|
43.2 | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
52.1 | - | - | $ 2.94 B | ||
|
Change Healthcare
CHNG
|
87 | - | - | $ 9.03 B | ||
|
Castlight Health, Inc.
CSLT
|
68.7 | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
-587 | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
56.1 | - | - | $ 6.37 B | ||
|
iCAD
ICAD
|
117 | - | - | $ 102 M | ||
|
Evolent Health
EVH
|
183 | $ 2.88 | 14.74 % | $ 270 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
71 | - | -10.39 % | $ 886 M | ||
|
GoodRx Holdings
GDRX
|
-124 | $ 2.32 | 4.04 % | $ 895 M | ||
|
MTBC
MTBC
|
42.2 | - | -0.58 % | $ 51.7 M | ||
|
Akerna Corp.
KERN
|
-5.62 | - | - | $ 161 M | ||
|
NextGen Healthcare
NXGN
|
37.1 | - | - | $ 1.6 B | ||
|
10x Genomics
TXG
|
167 | $ 25.35 | 2.22 % | $ 2.97 B | ||
|
OptimizeRx Corporation
OPRX
|
125 | $ 6.4 | 5.79 % | $ 110 M | ||
|
1Life Healthcare
ONEM
|
39.8 | - | - | $ 3.37 B | ||
|
Health Catalyst
HCAT
|
44.4 | $ 1.23 | 9.82 % | $ 86 M | ||
|
HealthEquity
HQY
|
21.5 | $ 83.67 | 2.84 % | $ 7.21 B | ||
|
Premier
PINC
|
110 | - | - | $ 2.33 B | ||
|
Schrödinger
SDGR
|
192 | $ 12.4 | 4.11 % | $ 911 M | ||
|
Phreesia
PHR
|
21.2 | $ 9.06 | 5.35 % | $ 541 M | ||
|
R1 RCM
RCM
|
21.9 | - | - | $ 3.81 B | ||
|
Teladoc Health
TDOC
|
28.2 | $ 5.54 | 5.62 % | $ 976 M | ||
|
Signify Health
SGFY
|
214 | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
59.4 | - | - | $ 21.4 M | ||
|
NantHealth
NH
|
-54.1 | - | -46.64 % | $ 10.4 M | ||
|
SCWorx Corp.
WORX
|
43.5 | - | - | $ 7.71 M | ||
|
American Well Corporation
AMWL
|
84.9 | $ 6.24 | 14.39 % | $ 100 M | ||
|
Tabula Rasa HealthCare
TRHC
|
12 | - | - | $ 255 M | ||
|
HealthStream
HSTM
|
14.1 | $ 21.04 | 3.44 % | $ 639 M | ||
|
Omnicell
OMCL
|
112 | $ 37.53 | 3.3 % | $ 1.73 B | ||
|
So-Young International
SY
|
87 | $ 2.74 | -0.72 % | $ 218 M | ||
|
Veeva Systems
VEEV
|
114 | $ 167.3 | 5.16 % | $ 27.4 B | ||
|
Zhongchao
ZCMD
|
-31 | $ 2.03 | 2.27 % | $ 6.94 M |